Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

Development of an effective vaccine for prevention of infection with HIV would provide an important mechanism for controlling the AIDS epidemic. In the current study, the first clinical trial of a candidate HIV-1 vaccine initiated in the United States, the safety and immunogenicity of escalating dos...

Olles dieđut

Bibliográfalaš dieđut

Publikašuvnnas:	J Clin Invest
Váldodahkkit:	Kovacs, J A, Vasudevachari, M B, Easter, M, Davey, R T, Falloon, J, Polis, M A, Metcalf, J A, Salzman, N, Baseler, M, Smith, G E
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	American Society for Clinical Investigation 1993
Fáttát:	Research Article
Liŋkkat:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC294931/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7688766/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116667
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!